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Abstract
Objective
Risk prediction models can assist clinicians in making decisions. To boost the uptake of
these models in clinical practice, it is important that end-users understand how the model
works and can efficiently communicate its results. We introduce novel methods for interpret-
able model visualization.
Methods
The proposed visualization techniques are applied to two prediction models from the Fra-
mingham Heart Study for the prediction of intermittent claudication and stroke after atrial
fibrillation. We represent models using color bars, and visualize the risk estimation process
for a specific patient using patient-specific contribution charts.
Results
The color-based model representations provide users with an attractive tool to instantly
gauge the relative importance of the predictors. The patient-specific representations allow
users to understand the relative contribution of each predictor to the patient’s estimated
risk, potentially providing insightful information on which to base further patient manage-
ment. Extensions towards non-linear models and interactions are illustrated on an artificial
dataset.
Conclusion
The proposed methods summarize risk prediction models and risk predictions for specific
patients in an alternative way. These representations may facilitate communication
between clinicians and patients.
Introduction
The focus on risk prediction models is increasing in many areas of clinical research. These
tools can aid doctors in personalized decision-making regarding diagnosis, prognosis and
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treatment. Examples are the Nottingham Prognostic Index to allocate breast cancer patients to
risk groups, the Apache system to predict the risk of hospital mortality, the IOTA LR2 model
to estimate the risk of malignancy of ovarian tumors and the euroSCORE to calculate the pre-
dicted operative mortality for patients undergoing cardiac surgery [1–5]. However, prediction
models do not easily find their way to routine clinical practice. Practical obstacles are one issue:
ideally the models should seamlessly fit the clinician’s workflow, e.g. by being computerized,
automatic, and built in into electronic health records [6–8]. Another, sometimes undervalued
issue is that of clinical credibility [9]. One aspect of credibility is to have understanding of how
a model arrives at an estimated risk [10]. As a result, model representation and visualization
are essential issues in prediction modeling research. This is further strengthened by the rise of
shared decision-making and patient centeredness [11,12].
In many, if not most, risk prediction studies, details are given on aspects including the
choice of a suitable underlying model, the selection of relevant predictors, independent evalua-
tion of the models, discrimination and calibration performance [13–16]. Unfortunately, the
choice of the representation of the developed models for interpretation and practical use is
often overlooked [17], although this presentation is crucial in the relation between doctor and
patient [18]. Research articles typically represent a prediction model by means of the estimated
coefficients or a table with odds ratios or hazard ratios. However, interpreting these values is
non-intuitive and depends on the unit of the predictors [19–22]. Direct comparisons of coeffi-
cients and odds ratios for different predictors is therefore difficult in a clinical setting [20–23].
In addition, risk prediction models are often implemented in software tools that provide risk
estimates when predictor values are entered [24,25,26]. Although such implementations are
vital, the interpretability of the original model is lost. There is no information on how the
model arrived at the risk estimate by indicating which predictors contributed most. Hence, for
prognostic applications including predictors that can be influenced by the patient, the model
gives no direct insight into how the estimated risk could be lowered through changes in lifestyle
or medication.
To address this issue, different alternative model representations have been proposed.
Representing a logistic regression model or a Cox model by means of a nomogram [27,28] is
popular in certain areas. Alternatively, regression models can be approximated by means of
score systems [15,29]. The advantage of these systems is that a number of points is allocated
to each predictor value, with higher values indicating a larger contribution to the risk esti-
mate. A disadvantage is that there are no guidelines to choose the predictors values at which
the points change and as such the performance of the score system might be lower than that
of the original model. An alternative to this approach was recently proposed by Van Belle
et al [30]. In this methodological paper, a color coding was used to visualize score systems.
This representation of a score system is similar to the visualization of absolute risks by means
of checkerboard plots in the WHO/ISH risk prediction charts [31]. Other model representa-
tions include the rank-hazard plot that visualizes the relative importance of predictors in a
Cox regression model [32], the use of 3D and contour plots for the representation of interac-
tion effects [33] and the visualization of individualized risk predictions by means of bar-line
charts [34].
In this work, we propose to use color charts to visualize the prediction model and bar charts
to visualize the risk prediction process for individual patients. These methods provide attrac-
tive tools to understand and communicate the relative influence of each predictor in general as
well as for individual patients.
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Illustrative Examples from the Literature: The Framingham Heart
Study
The different visualization methods will be illustrated on models from the Framingham heart
study [35] to predict intermittent claudication [36] and stroke after atrial fibrillation [37]. The
model representations used in this Section are the table-based representations as reported in
the original articles [36,37] and on the website [35].
Intermittent claudication
The Framingham Heart Study has developed a pooled logistic regression model to estimate the
risk to develop intermittent claudication within 4 years, based on age (years), sex, serum cho-
lesterol level (mg/dL), the hypertension level (normal, high normal, stage 1 or stage 2), the
number of cigarettes smoked daily, whether the patient has diabetes and whether the patient
has coronary heart disease (CHD) [36]. The coefficients of the logistic regression model are
summarized in Table 1. To use this model on a patient, the predictor values need to be multi-
plied with the β-values given in the table to yield the contribution of each predictor (i.e. βpxp,
with xp the pth predictor). All these contributions are added to the intercept β0 to obtain the lin-
ear predictor, defined as
z ¼ b0 þ
Xd
p¼1
bpxp; ð1Þ
with d being the number of predictors. The estimated risk is then found as 1/(1+exp(-z)).
In order to facilitate the practical use of the model, the authors developed a score system.
The resulting score model is summarized in Tables 2 and 3. To use on a patient, the points cor-
responding to the value of each predictor are summed up to obtain the score (Table 2). The
risk is a monotonic function of this score and can be found in Table 3.
Stroke after atrial fibrillation
In this example, the Framingham heart study group used a Cox regression model to estimate
the risk of having a stroke after atrial fibrillation [37]. The model is based on age (years), sex,
systolic blood pressure (mmHg), whether the patient has diabetes mellitus and whether the
patient has had a prior stroke or transient ischemic attack (TIA). The study population exists
Table 1. Logistic regression coefficients for the intermittent claudication model.
Predictor β
Intercept -8.9152
Male sex 0.5033
Age 0.0372
Blood Pressure
Normal 0.0000
High Normal 0.2621
Stage 1 Hypertension 0.4067
Stage 2+ Hypertension 0.7977
Diabetes 0.9503
Cigarettes/d 0.0314
Cholesterol, mg/dL 0.0048
CHD 0.9939
doi:10.1371/journal.pone.0132614.t001
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of 705 individuals between 55 and 94 years of age, who had an occurrence of new-onset atrial
fibrillation, were not treated with warfarin at baseline, and did not have rheumatic mitral ste-
nosis. The model coefficients are summarized in S1 Table. To estimate the predicted 5-year
risk of stroke by means of the model, the predictor values are multiplied with their correspond-
ing coefficient and summed. The survival probability is then estimated as
SðtÞ ¼ S0ðtÞ
exp
Xd
p¼1
bpxp
Xd
p¼1
bpxp
 !
ð2Þ
with S0(t) being the estimated baseline survival function and xp the average of x
p. For this
example, the baseline survival at 5 years of follow-up was S0(5) = 0.8571 and the mean predic-
tor values for sex, age, systolic blood pressure, diabetes and prior stroke were 1.48, 75, 146, 0.15
and 0.14, respectively. The score system derived from this model is presented in S2 and S3
Tables. Risk estimates can be obtained from S3 Table in the same way as from Table 3.
Table 2. Table based representation of the intermittent claudication score system. The points corre-
sponding to the values of the predictors need to be added to each other to obtain the score (total number of
points).
Predictor range or level points
Sex male 3
female 0
Age 45–49 0
50–54 1
55–59 2
60–64 3
65–69 4
70–74 5
75–79 6
80–84 7
Cholesterol, mg/dL < 170 0
170–209 1
210–249 2
250–289 3
> 289 4
Blood pressure normal 0
high normal 1
stage 1 2
stage 2+ 4
Cigarettes/d, n 0 0
1–5 1
6–10 2
11–20 3
> 20 4
Diabetes no 0
yes 5
Coronary heart disease no 0
yes 5
doi:10.1371/journal.pone.0132614.t002
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Visualization Methods
Model representation
Fig 1 illustrates the use of a nomogram to represent the intermittent claudication model. This
figure was produced with the rms package in R (version 3.1.2). A nomogram consists of rulers
for each predictor, a points ruler and two rulers to convert the score (i.e. the points total) to a
risk estimate. Predictors with longer rulers have a higher impact on the risk estimate since the
range of the contributions of this predictor is broader. For each predictor the contribution to
the linear predictor can be found by drawing a vertical line from the predictor value up to the
points ruler at the top of the graph. Note that the obtained points are a scaled version of
bpxp min
i2D
ðbpxpi Þ; ð3Þ
where the second term in Eq 3 indicates the minimal contribution of predictor xp observed in
the data. The sum of all these points yields the ‘score’. The estimated risk of intermittent claudi-
cation is found by drawing a line from the ‘score’ ruler to the risk ruler.
Although we acknowledge the advantages of a nomogram to understand the relative contri-
butions of the predictors, we argue that the addition of color codes will improve direct interpre-
tation. Interpreting colors is very intuitive since we are used to do so in daily life (e.g. traffic
lights). Research in different areas also demonstrates the effect of colors on marketing, brand
recognition, attention, learning and comprehension. It is also reported that visual displays can
enhance the communication of risk [38,39]. We therefore propose to use the color-based repre-
sentation, as used in a paper by Van Belle et al for score systems [30]. Instead of a table-based
approach, Fig 2 uses the color-based method to present the score system for intermittent clau-
dication. The color corresponding to each predictor value corresponds to a number of points,
which is indicated within each colored interval. The patient's score is the sum of the points for
all predictors. This score is converted into a risk estimate by means of the last color bar where a
dark green color indicates a low risk and a light green to ecru color indicates high risk. This
Table 3. Conversion from points to risk for the intermittent claudication score system. To obtain a risk
estimate, the obtained score is linked with a risk estimate.
score estimate of 4-year probability
< 10 < 1%
10–12 1%
13–15 2%
16–17 3%
18 4%
19 5%
20 6%
21 7%
22 8%
23 10%
24 11%
25 13%
26 16%
27 18%
28 21%
29 24%
30 28%
doi:10.1371/journal.pone.0132614.t003
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visualization of the model allows users to instantly gauge which predictors contribute most to a
high risk estimate. In this case, older age and having diabetes or coronary heart disease strongly
contribute to the risk of intermittent claudication.
Given the advantages of the color-based representation of a score system, we propose to
extend this approach to continuous model representations. In addition to a table with model
coefficients (Table 1), the model can be visualized as in Fig 3. At the bottom of each bar the
Fig 1. Nomogram for the intermittent claudication (IC) model. Each predictor is provided with a ruler. In
order to obtain the contribution of a predictor to the prognostic index, the value of the predictor needs to be
indicated and a vertical line needs to be drawn from this value, up to the points ruler. Addition of the points
obtained for each predictor yields the score. The corresponding risk is found by drawing a vertical line from
the score to the risk ruler.
doi:10.1371/journal.pone.0132614.g001
Fig 2. Graphical representation of the intermittent claudication score system. The colors relate to the
points that are attributed to a predictor value. Dark green indicates a low contribution and light green to ecru a
high contribution to the risk. The points corresponding to the colors are indicated within each interval and by
means of the color legend. It is instantly seen that older age and having diabetes or coronary heart disease
have the highest contribution to the risk of intermittent claudication. Addition of all points corresponding to the
predictor values of a patient gives the score which can then be converted into a risk estimate by means of the
color bar at the bottom.
doi:10.1371/journal.pone.0132614.g002
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range of the predictor is indicated. The colors encode the contribution of the predictors to the
linear predictor using Eq 3, and the conversion from the color to the points is made by means
of the color bar at the right of the graph. The figure is used in the same way as Fig 2, and visua-
lizes how the various predictors influence the risk of intermittent claudication. Similar to
nomograms, it is difficult to extract the exact number of points for each predictor when repre-
senting continuous models. The bars mainly help to visualize the operation of the model, and
to assess the relative influence of the different predictor values. When implementing the model
online, it would be useful to add boxes next to each bar where the predictor values can be
entered. As a result, the entered predictor values can be indicated on the graph such that the
most influential values are instantly identified. This approach is visualized by means of the tri-
angles in Fig 3, which indicate the measurements for a fictitious patient (a 55-year old man,
with a high normal blood pressure and diabetes, who smokes 6 cigarettes a day and has a cho-
lesterol value of 190 mg/dL). Additionally, percentiles of the predictor variables as observed in
the training set can be added to the model visualization in order to identify extreme values.
This is visualized in S1 Fig for the stroke model by means of the dashed gray vertical lines. The
percentiles as shown on the figure are merely exemplary since the original data were not avail-
able to the authors. Finally, S2 Fig illustrates the color-based representation of the score system
for the risk of stroke after atrial fibrillation.
In the proposed visualization technique, it was chosen to represent the lowest contribution
of each predictor to the linear predictor by zero points. This is in analogy with nomograms.
Alternatively, zero points can be addressed to the predictor means or some other relevant
value. The definition of the zero value is important to correctly interpret the resulting
visualization.
In Figs 2 and 3 and S1 and S2 Figs, a sequential color map is used, the color of which is
based on recommendations of [40] w.r.t. whether the map is color-blind friendly, LCD friendly
and print friendly. Since the color map is to be used to indicate the change in contribution, a
rainbow color map, which may be familiar to most end users, was discarded since apparent
sharp changes in the visualization occur due to rainbow color map artifacts [41]. Additionally,
Fig 3. Graphical representation of the intermittent claudication model. For each predictor the range is
indicated below the color bar, and the color indicates the contribution to the linear predictor corresponding to
the predictor value. The colors are converted to points by means of the color legend at the right of the graph.
The sum of all points, i.e. the score, is then converted to the estimated risk by means of the color bar at the
bottom The triangles indicate the predictor values and the corresponding risk estimate for a 55 year old man
with a high blood pressure and diabetes, who smokes 6 cigarettes a day and has a cholesterol value of 190
mg/dL.
doi:10.1371/journal.pone.0132614.g003
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the rainbow color map lacks perceptual ordering such that users have to refer to the color leg-
end more often to interpret the result. In case one would like to set one particular patient (e.g.
the mean of the observed values in the training data) as a reference, one could opt to set the
contributions of these predictor values to zero. The use of a diverging color map (a color map
with a well-defined midpoint) in this particular case can aid to identify which contributions of
a new patient are below or above the reference. Although these features are implemented
within the software, we will not elaborate on these options here.
Patient-specific contribution charts
Specifying how the estimated risk is obtained for specific patients can be important to decide
upon the most appropriate treatment for each individual [34]. We use the additive model
structure, where the linear predictor is found as a weighted sum of predictor values, as the basis
of the representation schemes that we propose. The contribution of each predictor xp to this
linear predictor is then βpxp. We present two graphical representations of patient-specific con-
tributions. The first representation is based on the visualization of marginal effects for black-
box models by Strumbelj and Kononenko [42]. In order to visualize which predictors contrib-
ute the most to the score for a particular patient, the contributions can be represented by
means of bar charts. The largest bar corresponds to the predictor that contributes the most to
the score and hence to the risk. This approach is visualized for the intermittent claudication
model in Figs 4 and 5 for two different patients: a 55-year old man, with a high normal blood
pressure and diabetes, who smokes 6 cigarettes a day and has a cholesterol value of 190 mg/dL;
and an 80-year old man with stage 1 hypertension, diabetes, a cholesterol value of 289 mg/dL
and coronary heart disease, who smokes 30 cigarettes a day. The observed values are indicated
in blue at the right-hand side next to the predictor bar. The gray bars indicate the contributions
of each predictor, which are computed as in Eq 3. At the bottom of the figure, the sum of all
these contributions (the score) and the corresponding risk estimate are given. Note that for
models including an intercept, it is not necessary to include this in the graph as it is taken into
account in the conversion from score to risk estimate. The horizontal black lines through each
Fig 4. Contribution chart for the intermittent claudication model for a patient with a good prognosis: a
55 year old man with a high blood pressure and diabetes, who smokes 6 cigarettes a day and has a
cholesterol value of 190 mg/dL. The black lines indicate the range of contributions for each predictor as
observed in the data set. The bars indicate the predictors’ contributions to the linear predictor for this specific
patient. The patient-specific predictor values are indicated in blue. The score at the bottom of the graph is the
sum of all predictor contributions. The estimated risk of intermittent claudication corresponding to this score is
given as well.
doi:10.1371/journal.pone.0132614.g004
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bar indicate the minimal and maximal contribution of this predictor as observed in the training
set. From these visualizations it is clearly seen that the second patient has more predictor values
that contribute to a high risk estimate.
The second representation of patient-specific predictor contributions uses the cumulative
score values to visualize the addition of different contributions to the final score. This approach
is used for the risk of stroke after atrial fibrillation in Figs 6 and 7 for two different patients: a
60-year old man with a systolic blood pressure of 120 mm Hg; and an 80-year old woman with
a systolic blood pressure of 183 mm Hg, diabetes and a prior stroke or TIA. Typical for this
Fig 5. Contribution chart for the intermittent claudication model for a patient with a bad prognosis: an
80-year old man with stage 1 hypertension, diabetes, a cholesterol value of 289 mg/dL and coronary
heart disease, who smokes 30 cigarettes a day. The black lines indicate the range of contributions for
each predictor as observed in the data set. The bars indicate the predictors’ contributions to the linear
predictor for this specific patient. The patient-specific predictor values are indicated in blue. The score at the
bottom of the graph is the sum of all predictor contributions. The estimated risk of intermittent claudication
corresponding to this score is given as well.
doi:10.1371/journal.pone.0132614.g005
Fig 6. Cumulative contribution chart representing patient-specific predictor contributions for the
strokemodel for a patient with a good prognosis: a 60-year old man with a systolic blood pressure of
120 mmHg. For each predictor the contribution to the linear predictor or score is represented by means of a
bar, each of which starts where the previous ended. The score is the sum of all these contributions. An extra
bar indicates the maximal score observed in the data set. The estimated risks corresponding to this patient's
score and the most extreme score observed in the data set is visualized as well. For this application, we
chose to represent an estimated risk of 10% or higher by a red color, representing a bad prognosis. Lower
risk estimates are visualized in green.
doi:10.1371/journal.pone.0132614.g006
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cumulative chart is that each bar starts where the previous bar ended. This plot shows how the
score is built up from the predictor contributions. Due to the cumulative nature, the score is
naturally obtained after addition of the contributions of the last predictor. The contributions
are computed as in Eq 3. For each predictor, the value is indicated in blue to the right of the
predictor’s name. The contribution to the score is indicated in grey. The score and the corre-
sponding risk estimates are shown by colored bars below the predictor contributions. Addi-
tional bars indicate the highest score and risk estimate observed in the training set. In this
example, it was chosen to show a risk below 10% in green. Higher risk estimates are indicated
in red. In practice, more colors can be used, which might indicate different procedures to be
followed for patients with different risk profiles.
In some cases, it might be insightful to sort the predictors by increasing contributions to the
score. This option is illustrated for the contribution chart in S3 Fig and for the cumulative con-
tributions chart in S4 Fig.
Extensions towards Nonlinear Models and Interaction Effects
For non-linear models the predictor contributions become βpfp(xp), with fp(xp) a non-linear
transformation of the predictor xp, such as logarithmic or power transformations or restricted
cubic splines. A non-linear effect can be represented in the same way as before, where the color
of each color bar will now represent βpfp(xp) instead of βpxp. The presented visualizations can
be further extended to include interaction effects. For each interaction effect, an additional
color plot is added to the model representation. For the patient-specific representations, a bar
is added with length
bp;qf p;qðxp; xqÞ min
i2D
bp;qf p;qðxpi ; xqi Þ
 
; ð4Þ
with βp,q the coefficient of the interaction and fp,q(xp, xq) a transformation on both predictors
involved in the interaction. This approach is illustrated in Fig 8 for an artificial example with 4
predictors: gender (binary), age (continuous), smoker (binary) and a biomarker (continuous).
The visualized model is a logistic regression model with z = -1 + β1 gender + β2 (age– 60)2 +
Fig 7. Cumulative contribution chart representing patient-specific predictor contributions for the
strokemodel for a patient with a bad prognosis: an 80-year old womanwith a systolic blood pressure
of 183 mmHg, diabetes and a prior stroke or TIA. For each predictor the contribution to the linear predictor
or score is represented by means of a bar, each of which starts where the previous ended. The score is the
sum of all these contributions. An extra bar indicates the maximal score observed in the data set. The
estimated risks corresponding to this patient's score and the most extreme score observed in the data set is
visualized as well. For this application, we chose to represent an estimated risk of 10% or higher by a red
color, representing a bad prognosis. Lower risk estimates are visualized in green.
doi:10.1371/journal.pone.0132614.g007
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β3 smoker + β4 biomarker + β5 gender((age-60)/10)3 + β6 gendersmoker + β7 (age-
60)2

biomarker, with β1 = -2, β2 = 0.005, β3 = 3, β4 = -0.02, β5 = 0.3, β6 = -2.5, and β7 = 0.00005.
In addition to linear main effects, this model contains a non-linear main effect for age, an inter-
action effect between gender and age, an interaction effect between gender and smoker and an
interaction effect between age and biomarker. In addition to the model visualization, the 5th
and 95th percentile (for continuous predictors) have been added in dashed gray lines in Fig 8.
The predictor values for one specific patient (a 62 year old smoking woman with a biomarker
level of 82 U/mL) together with the estimated risk are indicated by means of the triangles and
diamonds. The contribution chart for this patient is given in S5 Fig, where a contribution for
all relevant interaction effects is added in addition to the contributions of the main effects.
The methods can even be further extended towards kernel-based methods such as support
vector machines [43,44], as long as the chosen kernel is additive.
Software
The figures in this work are generated in R (version 3.1.2). An R package gathering all function-
ality described above is available at our website (http://homes.esat.kuleuven.be/~sistawww/
biomed/iota/index.php/mr/14-uncategorised/mr/61-visualization). The package also provides
different options regarding the color map and the level of the contributions that should be rep-
resented as zero. More information can be found in the manual that can be downloaded from
the same website.
Fig 8. Graphical representation of an artificial logistic model that includes non-linear functional forms
and interaction effects. For each predictor or interaction, the range is indicated below or next to the color
bars and color plots. The color indicates the contribution to the linear predictor corresponding to the predictor
values. The colors are converted to points by means of the color legend at the right of the graph. The sum of
all points, i.e. the score, is then converted to the estimated risk by means of the color bar at the bottom. The
triangles/diamonds indicate the predictor values and the corresponding risk estimate for a specific patient.
The dashed gray lines are used to show percentiles.
doi:10.1371/journal.pone.0132614.g008
Visualizing Risk Prediction Models
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Discussion
Interpretation of risk prediction models, even the simplest ones, is not straightforward for cli-
nicians and their patients. The most common representation type is a table of odds/hazard
ratios that are not intuitive and often interpreted incorrectly. Research shows that patients pre-
fer graphical representations of risk above numerical risk estimates, as this improves their com-
prehension of risk [38]. This work presents visualization methods to represent risk prediction
models and patient-specific contribution charts to enhance interpretation of these models. The
color-based model representation offers an alternative to nomograms for visualizing prediction
models. Nomograms use line segments of varying length to show the influence of the predic-
tors, whereas the color plots use bars of fixed length with varying color schemes. Colors are
known to be attractive and understandable, and are used often in risk charts [45]. The color
plots may be more convenient in communicating nonlinear effects such as quadratic terms and
interactions between two continuous predictors. The approach to visualize interaction terms
bears resemblance to recent work by Lamina and colleagues, and is easily incorporated in the
color plots [33].
The color schemes in the plots visualize how the model obtains a risk estimate, and thus
allows indicating the most contributing predictors for a specific patient. When interpreting col-
ors, care needs to be taken with respect to the reference values of the predictors. The interpreta-
tion depends on which value of the functional form is taken to be zero. Although the
underlying model is the same, contributions can be negative as well as positive in case a refer-
ence (e.g. the median observation) is set, making it more difficult to see which predictors con-
tribute the most. The indication of percentiles and predictor values of one particular patient in
an online implementation tool enables to indicate extreme values and to interpret how a
patient’s estimated risk is established, respectively.
To further enhance interpretation and communication, we also proposed to visualize the
risk estimation process for a specific patient by means of bar charts. The first type of contribu-
tion charts represents the contributions directly and offer the advantage that the maximal con-
tribution within the training set is represented, such that extreme values can be detected easily.
The cumulative contribution charts directly show how the linear predictor is built based on the
predictors and how the risk is situated within the risk estimates observed in the training set.
Additional colors can be used to give advice on the optimal treatment for a specific patient. For
this purpose, communication with clinical experts is a necessity but this communication is also
facilitated by these graphs. The patient-specific plots relate to the bar-line charts from Björk
and colleagues [34]. Their bar-line plots, however, are based on a sequential inclusion of pre-
dictors and hence results are order-dependent. This is inconsistent with nomograms and color
plots, which show independent contributions of all predictors to the risk. The sequential
approach restricts their use to communicate individual contributions, despite the fact that a
logical order could be discerned with respect to the priority of types of predictors: depending
on context, it can be defended that the value of simple demographic predictors is investigated
first, followed by specific disease characteristics and finally by advanced predictors such as
genetic parameters or complex imaging-based measurements.
Although the literature states that graphically representing risks enhances the comprehen-
sion of risk [38], evidence of the improved interpretability and acceptance of risk prediction
models by clinicians by visualizing them as proposed here can only be provided after conduct-
ing a user study, an example of which can be found in [46]. Different application areas could
prefer different settings and might as well prefer different visualization methods. User studies
should therefore be application specific and investigate whether the used visualization tech-
nique and applied color map are able to report what the end user needs. Questions that need to
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be answered are: do the users understand this representation and do they want to adopt this
representation in their work flow.
Using visualization methods has several advantages over current methods such as odds and
hazard ratios to summarize risk prediction methods. Without model visualization, the risk esti-
mate may be the only directly interpretable result of a risk prediction model available to the cli-
nician. However, optimal treatment might be very different for patients with the same risk
estimate. A simple example involves the treatment of breast cancer. Two patients with the
same risk estimate may require different treatment, for example because of a different estrogen
receptor status. Hormonal therapy will only benefit the patient with estrogen-positive cancer.
We realize that prediction models only relate measurements to a disease of interest without
necessarily implying a direct causal relationship. Nevertheless, understanding the operation of
prediction models is essential for thoughtful and successful use in practice. To this end, the
proposed visualization techniques are appealing tools in the communication between model
developers, model implementers and the clinical end-user, and will therefore result in software
tools that better fit the clinical workflow. Additionally, the clinician can use these techniques to
enhance communication with patients and to explain why a certain treatment is advised.
Supporting Information
S1 Fig. Graphical representation of the stroke model. For each predictor, the colors indicate
the contribution to the prognostic index, i.e. bpxp mini2Dðbpxpi Þ, wheremini2Dðbpxpi Þ indi-
cates the minimal contribution of predictor xp observed in the data. The points associated with
these colors can be extracted by means of the color legend at the right of the graph. The score,
obtained by summing all points, is translated into the risk estimate by means of the color bar at
the bottom of the graph. The dashed gray lines indicate how percentiles can be visualized to
detect extreme values in new patients. Note that the exact values for the percentiles are not rep-
resentative for this dataset since the original data were not available to the authors.
(PDF)
S2 Fig. Graphical representation of the stroke score system. The points corresponding to
each color are indicated within each interval and in the color legend. Summation of all points
results in the score, which is then converted into a risk estimate by means of the bottom most
color bar.
(PDF)
S3 Fig. Contribution chart for the intermittent claudication model. The predictors are
sorted according to increasing contributions to the score. The black lines indicate the range of
contributions for each predictor as observed in the data set. The bars indicate the predictors’
contributions to the linear predictor for this specific patient. The patient-specific predictor val-
ues are indicated in blue. The score at the bottom of the graph is the sum of all predictor contri-
butions. The estimated risk of intermittent claudication corresponding to this score is given as
well. (a) A 55 year old man with a high blood pressure and diabetes, who smokes 6 cigarettes a
day and has a cholesterol value of 190 mg/dL. (b) An 80-year old man with stage 1 hyperten-
sion, diabetes, a cholesterol value of 289 mg/dL and coronary heart disease, who smokes 30 cig-
arettes a day.
(PDF)
S4 Fig. Cumulative contribution chart representing patient-specific predictor contribu-
tions for the stroke model. The predictors are sorted according to increasing contributions to
the score. For each predictor the contribution to the linear predictor or score is represented by
means of a bar, each of which starts where the previous ended. The score is the sum of all these
Visualizing Risk Prediction Models
PLOS ONE | DOI:10.1371/journal.pone.0132614 July 15, 2015 13 / 16
contributions. An extra bar indicates the maximal score observed in the data set. The estimated
risks corresponding to this patient's score and the most extreme score observed in the data set
is visualized as well. For this application, we chose to represent an estimated risk of 10% or
higher by a red color, representing a bad prognosis. Lower risk estimates are visualized in
green. (a) A 60-year old man with a systolic blood pressure of 120 mm Hg. (b) An 80-year old
woman with a systolic blood pressure of 183 mm Hg, diabetes and a prior stroke or TIA.
(PDF)
S5 Fig. Contribution chart for the artificial model for a 62-year old smoking female with a
biomarker level of 82. The black lines indicate the range of contributions for each predictor as
observed in the data set. The bars indicate the predictors’ contributions to the linear predictor
for this specific patient. The patient-specific predictor values are indicated in blue. The score at
the bottom of the graph is the sum of all predictor contributions. The estimated risk corre-
sponding to this score is given as well.
(PDF)
S1 Table. Coefficients of the Cox model for the prediction of stroke after atrial fibrillation.
TIA: transient ischemic attack.
(PDF)
S2 Table. Table based representation of the stroke after atrial fibrillation score system. The
points corresponding to the values of the predictors need to be added to each other to obtain
the score (total number of points).
(PDF)
S3 Table. Conversion from points to risk for the stroke after atrial fibrillation score system.
To obtain a risk estimate, the obtained score is linked with a risk estimate.
(PDF)
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